REG - Bellway PLC - Employee Benefit Trust Share Purchase

BellwayAnnouncement

Today 14:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260413:nRSM2485Aa&default-theme=true

RNS Number : 2485A  Bellway PLC  13 April 2026

BELLWAY p.l.c.

 

EMPLOYEE BENEFIT TRUST SHARE PURCHASE

 

13 APRIL 2026

 

Bellway p.l.c. (the "Company") announces that it has been notified that on the
10 April 2026 Howells Trustees Limited, acting as trustee of the Bellway
p.l.c. Employee Benefit Trust (the "EBT"), purchased 48,893 ordinary shares in
the capital of the Company at an average cost of £20.3105 per share.

 

The shares will be held in the EBT, which is a discretionary trust for the
benefit of the Group's employees and will ultimately be used to satisfy share
awards and options granted under the Company's various share incentive
arrangements.

 

The Executive Directors and Persons Discharging Managerial Responsibility of
the Company, together with other employees, are included in the potential
beneficiaries of the EBT and are therefore treated as having an interest in
some of those shares and the dealings thereof.

 

Immediately following settlement of the above transaction, the EBT will hold
463,997 ordinary shares ("EBT Shares").

 

The Company's issued share capital as at 13 April 2026 consists of 116,156,371
ordinary shares of 12.5 pence each with voting rights. The Company does not
hold any shares in treasury and has waived its right to exercise its voting
rights and to receive dividends in respect of the EBT Shares. Therefore, the
total number of voting rights is 115,692,374.

 

 

 

 

Name of contact and telephone number for queries:

 

Phil Hope

Group Finance Director and Company Secretary

Bellway p.l.c.

Tel: 0191 217 0717

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCGPUQPCUPQGWW



            Copyright 2019 Regulatory News Service, all rights reserved